Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001437749-20-013874

Options or other derivatives

  • Chief R&D Officer acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Cavanagh William Chief R&D Officer 2020-06-23 Grant or award · Stock Options (right to buy) +150,000 701,660 D
Loading xslF345X03/rdgdoc.xml…